Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam
Authors:
- 16 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 353, 823-831
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative CouncilThe Journal of Pain, 2016
- Release Kinetics Study of Poorly Water-Soluble Drugs from Nanoparticles: Are We Doing It Right?Molecular Pharmaceutics, 2015
- Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis MethodMolecular Pharmaceutics, 2013
- Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systemsJournal of Pharmacy and Pharmacology, 2012
- Control of encapsulation efficiency and initial burst in polymeric microparticle systemsArchives of Pharmacal Research, 2004
- Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere BlendsPharmaceutical Research, 2001
- Protein Instability in Poly(Lactic-co-Glycolic Acid) MicroparticlesPharmaceutical Research, 2000
- Structure and physicochemical properties of meloxicam, a new NSAIDEuropean Journal of Pharmaceutical Sciences, 1996
- A Review of the Clinical Pharmacokinetics of MeloxicamRheumatology, 1996
- Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal toleranceInflammation Research, 1995